Skip to main content
Top
Published in: Quality of Life Research 12/2023

Open Access 04-08-2023 | Crohn's Disease

Validation of the bowel urgency numeric rating scale in patients with Crohn’s disease: results from a mixed methods study

Authors: Marla C. Dubinsky, Laure Delbecque, Theresa Hunter, Gale Harding, Larissa Stassek, Richard E. Moses, James D. Lewis

Published in: Quality of Life Research | Issue 12/2023

Login to get access

Abstract

Purpose

Bowel urgency (BU) is an important symptom of Crohn’s disease (CD), however there is no patient-reported outcome (PRO) scale validated in this population to assess BU severity. Here we evaluated the content validity and psychometric properties of the Urgency Numeric Rating Scale (NRS).

Method

Qualitative interviews were conducted with moderate-to-severe CD participants to confirm importance and relevance of BU in this population, cognitively debrief the Urgency NRS, and explore score interpretation and CD remission. A quantitative web survey study was conducted to explore the measurement properties of the urgency NRS.

Results

Qualitative Interview: 34 of 35 participants reported BU. It was most bothersome for 44%, 47% reported it daily, 18% with every bowel movement. BU had a severe impact on daily activities, causing many participants to stay home more than preferred. Patients confirmed the relevance, appropriateness, comprehensibility of the item, recall period, response options, and instructions of the Urgency NRS. Small reductions on the Urgency NRS score reflected meaningful improvements. Quantitative survey: The study sample comprised 76 participants (65.8% female). Mean Urgency NRS score was 4.7 (SD 2.26; N = 76) at Week 1, with no floor/ceiling effect. Test–retest reliability was acceptable. Construct and known-groups validity against selected PROs were overall strong and within ranges hypothesized a priori.

Conclusion

The Urgency NRS is a valid and reliable instrument to assess BU severity in CD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kalla, R., Ventham, N. T., Satsangi, J., & Arnott, I. D. (2014). Crohn’s disease. The BMJ, 349, g6670.CrossRefPubMed Kalla, R., Ventham, N. T., Satsangi, J., & Arnott, I. D. (2014). Crohn’s disease. The BMJ, 349, g6670.CrossRefPubMed
2.
3.
go back to reference Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., Sung, J. J. Y., & Kaplan, G. G. (2017). Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet, 390(10114), 2769–2778.CrossRefPubMed Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., Sung, J. J. Y., & Kaplan, G. G. (2017). Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet, 390(10114), 2769–2778.CrossRefPubMed
4.
go back to reference Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., & Kaplan, G. G. (2012). Increasing incidence and prevalence of the inflammatory Bowel diseases with time, based on systematic review. Gastroenterology, 142(1), 46-54.e42. quiz e30.CrossRefPubMed Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., & Kaplan, G. G. (2012). Increasing incidence and prevalence of the inflammatory Bowel diseases with time, based on systematic review. Gastroenterology, 142(1), 46-54.e42. quiz e30.CrossRefPubMed
5.
go back to reference Nobrega, V. G., Silva, I. N. N., Brito, B. S., Silva, J., Silva, M., & Santana, G. O. (2018). The Onset of Clinical Manifestations in Inflammatory Bowel Disease Patients. Arquivos de Gastroenterologia, 55(3), 290–295.CrossRefPubMed Nobrega, V. G., Silva, I. N. N., Brito, B. S., Silva, J., Silva, M., & Santana, G. O. (2018). The Onset of Clinical Manifestations in Inflammatory Bowel Disease Patients. Arquivos de Gastroenterologia, 55(3), 290–295.CrossRefPubMed
6.
go back to reference Dulai, P. S., Jairath, V., Khanna, R., Ma, C., McCarrier, K. P., Martin, M. L., Parker, C. E., Morris, J., Feagan, B. G., & Sandborn, W. J. (2020). Development of the symptoms and impacts questionnaire for Crohn’s disease and ulcerative colitis. Alimentary Pharmacology & Therapeutics, 51(11), 1047–1066.CrossRef Dulai, P. S., Jairath, V., Khanna, R., Ma, C., McCarrier, K. P., Martin, M. L., Parker, C. E., Morris, J., Feagan, B. G., & Sandborn, W. J. (2020). Development of the symptoms and impacts questionnaire for Crohn’s disease and ulcerative colitis. Alimentary Pharmacology & Therapeutics, 51(11), 1047–1066.CrossRef
7.
go back to reference Petryszyn, P. W., & Paradowski, L. (2018). Stool patterns and symptoms of disordered anorectal function in patients with inflammatory Bowel diseases. Advances in Clinical and Experimental Medicine, 27(6), 813–818.CrossRefPubMed Petryszyn, P. W., & Paradowski, L. (2018). Stool patterns and symptoms of disordered anorectal function in patients with inflammatory Bowel diseases. Advances in Clinical and Experimental Medicine, 27(6), 813–818.CrossRefPubMed
8.
go back to reference Casellas, F., Herrera-de Guise, C., Robles, V., Navarro, E., & Borruel, N. (2017). Patient preferences for inflammatory Bowel disease treatment objectives. Digestive and Liver Disease, 49(2), 152–156.CrossRefPubMed Casellas, F., Herrera-de Guise, C., Robles, V., Navarro, E., & Borruel, N. (2017). Patient preferences for inflammatory Bowel disease treatment objectives. Digestive and Liver Disease, 49(2), 152–156.CrossRefPubMed
9.
go back to reference Higgins, P. D. R., Harding, G., Leidy, N. K., DeBusk, K., Patrick, D. L., Viswanathan, H. N., Fitzgerald, K., Donelson, S. M., Cyrille, M., Ortmeier, B. G., Wilson, H., Revicki, D. A., & Globe, G. (2017). Development and validation of the Crohn’s disease patient-reported outcomes signs and symptoms (CD-PRO/SS) diary. Journal of Patient Reported Outcomes, 2(1), 24.CrossRefPubMed Higgins, P. D. R., Harding, G., Leidy, N. K., DeBusk, K., Patrick, D. L., Viswanathan, H. N., Fitzgerald, K., Donelson, S. M., Cyrille, M., Ortmeier, B. G., Wilson, H., Revicki, D. A., & Globe, G. (2017). Development and validation of the Crohn’s disease patient-reported outcomes signs and symptoms (CD-PRO/SS) diary. Journal of Patient Reported Outcomes, 2(1), 24.CrossRefPubMed
10.
go back to reference van Deen, W. K., Kiaei, B., Weaver, S. A., Crate, D. J., Kwon, M. H., Shah, S. A., Melmed, G. Y., & Siegel, C. A. (2020). A qualitative inquiry into patients’ perspectives on individualized priorities for treatment outcomes in inflammatory bowel diseases. Quality of Life Research, 29(9), 2403–2414.CrossRefPubMed van Deen, W. K., Kiaei, B., Weaver, S. A., Crate, D. J., Kwon, M. H., Shah, S. A., Melmed, G. Y., & Siegel, C. A. (2020). A qualitative inquiry into patients’ perspectives on individualized priorities for treatment outcomes in inflammatory bowel diseases. Quality of Life Research, 29(9), 2403–2414.CrossRefPubMed
11.
go back to reference Norton, C., Dibley, L. B., & Bassett, P. (2013). Faecal incontinence in inflammatory bowel disease: Associations and effect on quality of life. Journal of Crohn’s and Colitis, 7(8), e302-311.CrossRefPubMed Norton, C., Dibley, L. B., & Bassett, P. (2013). Faecal incontinence in inflammatory bowel disease: Associations and effect on quality of life. Journal of Crohn’s and Colitis, 7(8), e302-311.CrossRefPubMed
12.
go back to reference Rubin, D. T., Sninsky, C., Siegmund, B., Sans, M., Hart, A., Bressler, B., Bouhnik, Y., Armuzzi, A., & Afzali, A. (2021). International perspectives on management of inflammatory Bowel Disease: Opinion differences and similarities between patients and physicians from the IBD GAPPS Survey. Inflammatory Bowel Diseases, 27(12), 1942–1953.CrossRefPubMedPubMedCentral Rubin, D. T., Sninsky, C., Siegmund, B., Sans, M., Hart, A., Bressler, B., Bouhnik, Y., Armuzzi, A., & Afzali, A. (2021). International perspectives on management of inflammatory Bowel Disease: Opinion differences and similarities between patients and physicians from the IBD GAPPS Survey. Inflammatory Bowel Diseases, 27(12), 1942–1953.CrossRefPubMedPubMedCentral
13.
go back to reference Louis, E., Ramos-Goñi, J. M., Cuervo, J., Kopylov, U., Barreiro-de Acosta, M., McCartney, S., Rosenfeld, G., Bettenworth, D., Hart, A., Novak, K., Donnet, X., Easton, D., Saldaña, R., Protze, K., Tzur, E., Alperovich, G., & Casellas, F. (2020). A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective. The Patient - Patient-Centered Outcomes Research, 13(3), 317–325.CrossRefPubMed Louis, E., Ramos-Goñi, J. M., Cuervo, J., Kopylov, U., Barreiro-de Acosta, M., McCartney, S., Rosenfeld, G., Bettenworth, D., Hart, A., Novak, K., Donnet, X., Easton, D., Saldaña, R., Protze, K., Tzur, E., Alperovich, G., & Casellas, F. (2020). A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective. The Patient - Patient-Centered Outcomes Research, 13(3), 317–325.CrossRefPubMed
15.
go back to reference Buchmann, P., Kolb, E., & Alexander-Williams, J. (1981). Pathogenesis of urgency in defaecation in Crohn’s disease. Digestion, 22(6), 310–316.CrossRefPubMed Buchmann, P., Kolb, E., & Alexander-Williams, J. (1981). Pathogenesis of urgency in defaecation in Crohn’s disease. Digestion, 22(6), 310–316.CrossRefPubMed
16.
go back to reference Dawwas, G. K., Jajeh, H., Shan, M., Naegeli, A. N., Hunter, T., & Lewis, J. D. (2021). Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn’s disease in the study of a prospective adult research cohort with inflammatory bowel disease. Crohn’s & Colitis 360. https://doi.org/10.1093/crocol/otab046CrossRef Dawwas, G. K., Jajeh, H., Shan, M., Naegeli, A. N., Hunter, T., & Lewis, J. D. (2021). Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn’s disease in the study of a prospective adult research cohort with inflammatory bowel disease. Crohn’s & Colitis 360. https://​doi.​org/​10.​1093/​crocol/​otab046CrossRef
18.
go back to reference Dubinsky, M. C., Naegeli, A., Dong, Y., Lissoos, T., Arora, V., & Irving, P. (2020). The urgency numeric rating scale (NRS): A novel patient-reported outcome measure to assess bowel urgency in adult patients with ulcerative colitis. Journal of Crohn’s and Colitis, 14, S200–S200.CrossRef Dubinsky, M. C., Naegeli, A., Dong, Y., Lissoos, T., Arora, V., & Irving, P. (2020). The urgency numeric rating scale (NRS): A novel patient-reported outcome measure to assess bowel urgency in adult patients with ulcerative colitis. Journal of Crohn’s and Colitis, 14, S200–S200.CrossRef
19.
go back to reference Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E. (2018). ACG clinical guideline: Management of Crohn’s disease in adults. American Journal of Gastroenterology, 113(4), 481–517.CrossRefPubMed Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E. (2018). ACG clinical guideline: Management of Crohn’s disease in adults. American Journal of Gastroenterology, 113(4), 481–517.CrossRefPubMed
20.
go back to reference Guest, G., Bunce, A., & Johnson, L. (2006). How Many Interviews Are Enough?: An Experiment with Data Saturation and Variability. Field Methods, 18(1), 59–82.CrossRef Guest, G., Bunce, A., & Johnson, L. (2006). How Many Interviews Are Enough?: An Experiment with Data Saturation and Variability. Field Methods, 18(1), 59–82.CrossRef
21.
go back to reference Hennink, M. M., Kaiser, B. N., & Marconi, V. C. (2017). Code saturation versus meaning saturation: How many interviews are enough? Qualitative Health Research, 27(4), 591–608.CrossRefPubMed Hennink, M. M., Kaiser, B. N., & Marconi, V. C. (2017). Code saturation versus meaning saturation: How many interviews are enough? Qualitative Health Research, 27(4), 591–608.CrossRefPubMed
22.
go back to reference Friese, S., & Ringmayr, T. (2013). ATLAS.ti 7 User Guide and Reference. Berlin: ATLAS.ti Scientific Software Development GmBH. Friese, S., & Ringmayr, T. (2013). ATLAS.ti 7 User Guide and Reference. Berlin: ATLAS.ti Scientific Software Development GmBH.
23.
go back to reference Leidy, N. K., & Vernon, M. (2008). Perspectives on patient-reported outcomes. Pharmacoeconomics, 26(5), 363–370.CrossRefPubMed Leidy, N. K., & Vernon, M. (2008). Perspectives on patient-reported outcomes. Pharmacoeconomics, 26(5), 363–370.CrossRefPubMed
24.
go back to reference United States Food and Drug Administration. (2009). Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register, 74(2355). United States Food and Drug Administration. (2009). Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register, 74(2355).
25.
go back to reference Webster, K., Cella, D., & Yost, K. (2003). The functional assessment of chronic illness therapy (FACIT) measurement system: Properties, applications, and interpretation. Health and Quality of Life Outcomes, 1, 79.CrossRefPubMedPubMedCentral Webster, K., Cella, D., & Yost, K. (2003). The functional assessment of chronic illness therapy (FACIT) measurement system: Properties, applications, and interpretation. Health and Quality of Life Outcomes, 1, 79.CrossRefPubMedPubMedCentral
26.
go back to reference Targum, S. D., Hassman, H., Pinho, M., & Fava, M. (2012). Development of a clinical global impression scale for fatigue. Journal of Psychiatric Research, 46(3), 370–374.CrossRefPubMed Targum, S. D., Hassman, H., Pinho, M., & Fava, M. (2012). Development of a clinical global impression scale for fatigue. Journal of Psychiatric Research, 46(3), 370–374.CrossRefPubMed
27.
go back to reference Hays, R. D., & Revicki, D. A. (2005). Reliability and validity, including responsiveness. In P. M. Fayers & R. D. Hays (Eds.), Assessing Quality of Life in Clinical Trials (2nd ed., pp. 25–39). Oxford University Press.CrossRef Hays, R. D., & Revicki, D. A. (2005). Reliability and validity, including responsiveness. In P. M. Fayers & R. D. Hays (Eds.), Assessing Quality of Life in Clinical Trials (2nd ed., pp. 25–39). Oxford University Press.CrossRef
28.
go back to reference Aaronson, N., Alonso, J., Burnam, A., Lohr, K. N., Patrick, D. L., Perrin, E., & Stein, R. E. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11(3), 193–205.CrossRefPubMed Aaronson, N., Alonso, J., Burnam, A., Lohr, K. N., Patrick, D. L., Perrin, E., & Stein, R. E. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11(3), 193–205.CrossRefPubMed
29.
go back to reference Bujang, M. A., & Baharum, N. (2017). A simplified guide to determination of sample size requirements for estimating the value of intraclass correlation coefficient: A review. Archives of Orofacial Science, 12(1), 1–11. Bujang, M. A., & Baharum, N. (2017). A simplified guide to determination of sample size requirements for estimating the value of intraclass correlation coefficient: A review. Archives of Orofacial Science, 12(1), 1–11.
30.
go back to reference Hinkle, D. E., Wiersma, W., & Jurs, S. G. (1988). Applied Statistics for the Behavioral Sciences (2nd ed.). Houghton Mifflin. Hinkle, D. E., Wiersma, W., & Jurs, S. G. (1988). Applied Statistics for the Behavioral Sciences (2nd ed.). Houghton Mifflin.
31.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (Revised ed.). Lawrence Earlbaum Associates: Inc. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (Revised ed.). Lawrence Earlbaum Associates: Inc.
32.
go back to reference Nunnally, J. C., & Bernstein, I. (1994). Psychometric theory 3E. Tata McGraw-hill education. Nunnally, J. C., & Bernstein, I. (1994). Psychometric theory 3E. Tata McGraw-hill education.
33.
go back to reference Surti, B., Spiegel, B., Ippoliti, A., Vasiliauskas, E. A., Simpson, P., Shih, D. Q., Targan, S. R., McGovern, D. P., & Melmed, G. Y. (2013). Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale. Digestive Diseases and Sciences, 58(5), 1313–1321.CrossRefPubMed Surti, B., Spiegel, B., Ippoliti, A., Vasiliauskas, E. A., Simpson, P., Shih, D. Q., Targan, S. R., McGovern, D. P., & Melmed, G. Y. (2013). Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale. Digestive Diseases and Sciences, 58(5), 1313–1321.CrossRefPubMed
34.
go back to reference Dubinsky, M. C., Delbecque, L., Lewis, J., Hunter, T., & Shan, M. (2022). Psychometric validation and interpretation of a patient-reported outcomes instrument to assess bowel urgency among adults with moderate to severe Ulcerative Colitis. Journal of Crohn’s and Colitis, 16, P138.CrossRef Dubinsky, M. C., Delbecque, L., Lewis, J., Hunter, T., & Shan, M. (2022). Psychometric validation and interpretation of a patient-reported outcomes instrument to assess bowel urgency among adults with moderate to severe Ulcerative Colitis. Journal of Crohn’s and Colitis, 16, P138.CrossRef
35.
go back to reference Dibley, L., Khoshaba, B., Artom, M., Van Loo, V., Sweeney, L., Syred, J., Windgassen, S., Moffatt, G., & Norton, C. (2021). Patient strategies for managing the vicious cycle of fatigue, pain and urgency in inflammatory bowel disease: Impact, planning and support. Digestive Diseases and Sciences, 66(10), 3330–3342.CrossRefPubMed Dibley, L., Khoshaba, B., Artom, M., Van Loo, V., Sweeney, L., Syred, J., Windgassen, S., Moffatt, G., & Norton, C. (2021). Patient strategies for managing the vicious cycle of fatigue, pain and urgency in inflammatory bowel disease: Impact, planning and support. Digestive Diseases and Sciences, 66(10), 3330–3342.CrossRefPubMed
36.
go back to reference Smith, B. (2018). Generalizability in qualitative research: Misunderstandings, opportunities and recommendations for the sport and exercise sciences. Qualitative Research in Sport, Exercise and Health, 10(1), 137–149.CrossRef Smith, B. (2018). Generalizability in qualitative research: Misunderstandings, opportunities and recommendations for the sport and exercise sciences. Qualitative Research in Sport, Exercise and Health, 10(1), 137–149.CrossRef
Metadata
Title
Validation of the bowel urgency numeric rating scale in patients with Crohn’s disease: results from a mixed methods study
Authors
Marla C. Dubinsky
Laure Delbecque
Theresa Hunter
Gale Harding
Larissa Stassek
Richard E. Moses
James D. Lewis
Publication date
04-08-2023
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 12/2023
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-023-03494-y

Other articles of this Issue 12/2023

Quality of Life Research 12/2023 Go to the issue